Abdul Mannan: Venous Thromboembolism Prophylaxis Is Often Overlooked in Medical Inpatients
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn:
”Venous thromboembolism remains a leading cause of preventable hospital deaths, yet prophylaxis is often overlooked in medical inpatients. Evidence shows that systematic risk assessment using tools like the Padua Score, combined with bleeding-risk stratification (IMPROVE), saves lives. Pharmacological prophylaxis with LMWH reduces VTE by up to 50% in at-risk patients, whilst mechanical methods offer alternatives when bleeding risk is high. As clinicians, we must embed VTE assessment into daily practice—document decisions, reassess regularly, and champion mechanical prophylaxis when pharmacological options are contraindicated. Let’s ensure every patient receives the right prophylaxis at the right time. Prevention is always better than treatment.”
Learn more here.
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 31, 2026, 06:37Christian Schulze Presents The Post-Hoc Analysis of the DanGer Shock Trial
-
Jan 31, 2026, 06:27Negative Trials Matter: Anne Hege Aamodt Shares The TenCRAOS Trial
-
Jan 31, 2026, 06:18Manuel Requena: Cherrypicking Inclusion in Clinical Trials May Underestimate The Effect of An Intervention
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV